{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:24:09Z","timestamp":1790389449335,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s11886-008-0074-5","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T00:53:59Z","timestamp":1231376039000},"page":"470-476","source":"Crossref","is-referenced-by-count":16,"title":["In hypertension, the kidney breaks your heart"],"prefix":"10.1007","volume":"10","author":[{"given":"Steven D.","family":"Crowley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Coffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,9]]},"reference":[{"key":"74_CR1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1126\/science.2063193","volume":"252","author":"A.C. Guyton","year":"1991","unstructured":"Guyton AC: Blood pressure control-special role of the kidneys and body fluids. Science 1991, 252:1813\u20131816.","journal-title":"Science"},{"key":"74_CR2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0092-8674(01)00241-0","volume":"104","author":"R.P. Lifton","year":"2001","unstructured":"Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell 2001, 104:545\u2013556.","journal-title":"Cell"},{"key":"74_CR3","volume-title":"Drugs, Enzymes and Receptors of the Renin-Angiotensin System: Celebrating a Century of Discovery, vol 1","year":"2000","unstructured":"Husain A, Graham R, eds: Drugs, Enzymes and Receptors of the Renin-Angiotensin System: Celebrating a Century of Discovery, vol 1. Sidney: Harwood Academic; 2000."},{"key":"74_CR4","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1073\/pnas.92.8.3521","volume":"92","author":"M. Ito","year":"1995","unstructured":"Ito M, Oliverio MI, Mannon PJ, et al.: Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A 1995, 92:3521\u20133525.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"74_CR5","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1073\/pnas.92.7.2735","volume":"92","author":"H.S. Kim","year":"1995","unstructured":"Kim HS, Krege JH, Kluckman KD, et al.: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A 1995, 92:2735\u20132739.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"74_CR6","first-page":"953","volume":"74","author":"C.R. Esther Jr","year":"1996","unstructured":"Esther CR Jr, Howard TE, Marino EM, et al.: Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 1996, 74:953\u2013965.","journal-title":"Lab Invest"},{"key":"74_CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1074\/jbc.275.1.5","volume":"275","author":"K. Yanai","year":"2000","unstructured":"Yanai K, Saito T, Kakinuma Y, et al.: Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice. J Biol Chem 2000, 275:5\u20138.","journal-title":"J Biol Chem"},{"key":"74_CR8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/cbir.1996.0021","volume":"20","author":"S. Shanmugam","year":"1996","unstructured":"Shanmugam S, Sandberg K: Ontogeny of angiotensin II receptors. Cell Biol Int 1996, 20:169\u2013176.","journal-title":"Cell Biol Int"},{"key":"74_CR9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0031-6997(25)00446-6","volume":"45","author":"P.B. Timmermans","year":"1993","unstructured":"Timmermans PB, Wong PC, Chiu AT, et al.: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993, 45:205\u2013251.","journal-title":"Pharmacol Rev"},{"key":"74_CR10","doi-asserted-by":"crossref","unstructured":"Tharaux PL, Coffman TM: Transgenic mice as a tool to study the renin-angiotensin system. Contrib Nephrol 2001, (135): 72\u201391.","DOI":"10.1159\/000060158"},{"key":"74_CR11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/351233a0","volume":"351","author":"T.J. Murphy","year":"1991","unstructured":"Murphy TJ, Alexander RW, Griendling KK, et al.: Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 1991, 351:233\u2013236.","journal-title":"Nature"},{"key":"74_CR12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/351230a0","volume":"351","author":"K. Sasaki","year":"1991","unstructured":"Sasaki K, Yamano Y, Bardhan S, et al.: Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 1991, 351:230\u2013233.","journal-title":"Nature"},{"key":"74_CR13","first-page":"E260","volume":"267","author":"J.M. Burson","year":"1994","unstructured":"Burson JM, Aguilera G, Gross KW, Sigmund CD: Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol 1994, 267:E260\u2013E267.","journal-title":"Am J Physiol"},{"key":"74_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0303-7207(92)90101-B","volume":"90","author":"G. Aguilera","year":"1992","unstructured":"Aguilera G: Role of angiotensin II receptor subtypes on the regulation of aldosterone secretion in the adrenal glomerulosa zone in the rat. Mol Cell Endocrinol 1992, 90:53\u201360.","journal-title":"Mol Cell Endocrinol"},{"key":"74_CR15","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1172\/JCI7840","volume":"104","author":"S. Masilamani","year":"1999","unstructured":"Masilamani S, Kim GH, Mitchell C, et al.: Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest 1999, 104:R19\u2013R23.","journal-title":"J Clin Invest"},{"key":"74_CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0006-8993(02)02963-3","volume":"949","author":"M.J. Morris","year":"2002","unstructured":"Morris MJ, Wilson WL, Starbuck EM, Fitts DA: Forebrain circumventricular organs mediate salt appetite induced by intravenous angiotensin II in rats. Brain Res 2002, 949:42\u201350.","journal-title":"Brain Res"},{"key":"74_CR17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1172\/JCI10022","volume":"106","author":"R.L. Davisson","year":"2000","unstructured":"Davisson RL, Oliverio MI, Coffman TM, Sigmund CD: Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest 2000, 106:103\u2013106.","journal-title":"J Clin Invest"},{"key":"74_CR18","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1172\/JCI109774","volume":"65","author":"I. Ichikawa","year":"1980","unstructured":"Ichikawa I, Brenner BM: Importance of efferent arteriolar vascular tone in regulation of proximal tubule fluid reab-sorption and glomerulotubular balance in the rat. J Clin Invest 1980, 65:1192\u20131201.","journal-title":"J Clin Invest"},{"key":"74_CR19","first-page":"S81","volume":"20","author":"L.G. Navar","year":"1987","unstructured":"Navar LG, Carmines PK, Huang WC, Mitchell KD: The tubular effects of angiotensin II. Kidney Int Suppl 1987, 20:S81\u2013S88.","journal-title":"Kidney Int Suppl"},{"key":"74_CR20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.15.5.451","volume":"15","author":"M.G. Cogan","year":"1990","unstructured":"Cogan MG: Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 1990, 15:451\u2013458.","journal-title":"Hypertension"},{"issue":"Suppl11","key":"74_CR21","first-page":"S225","volume":"10","author":"P.D. Bell","year":"1999","unstructured":"Bell PD, Peti-Peterdi J: Angiotensin II stimulates macula densa basolateral sodium\/hydrogen exchange via type 1 angiotensin II receptors. J Am Soc Nephrol 1999, 10(Suppl 11):S225\u2013S229.","journal-title":"J Am Soc Nephrol"},{"key":"74_CR22","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.ASN.0000013292.78621.FD","volume":"13","author":"J. Peti-Peterdi","year":"2002","unstructured":"Peti-Peterdi J, Warnock DG, Bell PD: Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol 2002, 13:1131\u20131135.","journal-title":"J Am Soc Nephrol"},{"key":"74_CR23","first-page":"R960","volume":"250","author":"J.E. Hall","year":"1986","unstructured":"Hall JE: Control of sodium excretion by angiotensin IId: intrarenal mechanisms and blood pressure regulation. Am J Physiol 1986, 250:R960\u2013R972.","journal-title":"Am J Physiol"},{"key":"74_CR24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"B.M. Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, et al.: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001, 345:861\u2013869.","journal-title":"N Engl J Med"},{"key":"74_CR25","doi-asserted-by":"crossref","unstructured":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group [no authors listed]. N Engl J Med 1987, 316:1429\u20131435.","DOI":"10.1056\/NEJM198706043162301"},{"key":"74_CR26","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","volume":"345","author":"J.N. Cohn","year":"2001","unstructured":"Cohn JN, Tognoni G: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001, 345:1667\u20131675.","journal-title":"N Engl J Med"},{"key":"74_CR27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/01.HYP.35.2.550","volume":"35","author":"M.I. Oliverio","year":"2000","unstructured":"Oliverio MI, Best CF, Smithies O, Coffman TM: Regulation of sodium balance and blood pressure by the AT(1A) receptor for angiotensin II. Hypertension 2000, 35:550\u2013554.","journal-title":"Hypertension"},{"key":"74_CR28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1172\/JCI200523378","volume":"115","author":"S.D. Crowley","year":"2005","unstructured":"Crowley SD, Gurley SB, Oliverio MI, et al.: Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 2005, 115:1092\u20131099.","journal-title":"J Clin Invest"},{"key":"74_CR29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/35038011","volume":"407","author":"R. Brenner","year":"2000","unstructured":"Brenner R, Perez GJ, Bonev AD, et al.: Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature 2000, 407:870\u2013876.","journal-title":"Nature"},{"key":"74_CR30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.1065250","volume":"295","author":"Y. Zhu","year":"2002","unstructured":"Zhu Y, Bian Z, Lu P, et al.: Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002, 295:505\u2013508.","journal-title":"Science"},{"key":"74_CR31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.HYP.0000112225.27560.24","volume":"43","author":"H. Francois","year":"2004","unstructured":"Francois H, Athirakul K, Mao L, et al.: Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 2004, 43:364\u2013369.","journal-title":"Hypertension"},{"key":"74_CR32","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1084\/jem.20040995","volume":"201","author":"C. Vecchione","year":"2005","unstructured":"Vecchione C, Patrucco E, Marino G, et al.: Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma. J Exp Med 2005, 201:1217\u20131228.","journal-title":"J Exp Med"},{"key":"74_CR33","doi-asserted-by":"crossref","first-page":"17985","DOI":"10.1073\/pnas.0605545103","volume":"103","author":"S.D. Crowley","year":"2006","unstructured":"Crowley SD, Gurley SB, Herrera MJ, et al.: Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 2006, 103:17985\u201317990.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"74_CR34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0002-9343(72)90050-2","volume":"52","author":"A.C. Guyton","year":"1972","unstructured":"Guyton AC, Coleman TG, Cowley AV Jr, et al.: Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972, 52:584\u2013594.","journal-title":"Am J Med"},{"key":"74_CR35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-114-5-345","volume":"114","author":"M.J. Koren","year":"1991","unstructured":"Koren MJ, Devereux RB, Casale PN, et al.: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991, 114:345\u2013352.","journal-title":"Ann Intern Med"},{"key":"74_CR36","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D. Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, et al.: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322:1561\u20131566.","journal-title":"N Engl J Med"},{"key":"74_CR37","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","volume":"75","author":"J. Sadoshima","year":"1993","unstructured":"Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993, 75:977\u2013984.","journal-title":"Cell"},{"key":"74_CR38","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.1996.03530430051039","volume":"275","author":"R.E. Schmieder","year":"1996","unstructured":"Schmieder RE, Martus P, Klingbeil A: Reversal of left ventricular hypertrophy in essential hypertension. A metaanalysis of randomized double-blind studies. JAMA 1996, 275:1507\u20131513.","journal-title":"JAMA"},{"key":"74_CR39","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/hc3901.096700","volume":"104","author":"J. Mathew","year":"2001","unstructured":"Mathew J, Sleight P, Lonn E, et al.: Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001, 104:1615\u20131621.","journal-title":"Circulation"},{"key":"74_CR40","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/01.CIR.0000141573.44737.5A","volume":"110","author":"R.B. Devereux","year":"2004","unstructured":"Devereux RB, Dahlof B, Gerdts E, et al.: Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004, 110:1456\u20131462.","journal-title":"Circulation"},{"key":"74_CR41","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1073\/pnas.97.2.931","volume":"97","author":"P. Paradis","year":"2000","unstructured":"Paradis P, Dali-Youcef N, Paradis FW, et al.: Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci U S A 2000, 97:931\u2013936.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"74_CR42","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1073\/pnas.94.12.6391","volume":"94","author":"L. Hein","year":"1997","unstructured":"Hein L, Stevens ME, Barsh GS, et al.: Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci U S A 1997, 94:6391\u20136396.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"74_CR43","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1172\/JCI25330","volume":"115","author":"P. Zhai","year":"2005","unstructured":"Zhai P, Yamamoto M, Galeotti J, et al.: Cardiac-specific overexpression of AT1 receptor mutant lacking G{alpha}q\/G{alpha}i coupling causes hypertrophy and bradycardia in transgenic mice. J Clin Invest 2005, 115:3045\u20133056.","journal-title":"J Clin Invest"},{"key":"74_CR44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1172\/JCI113337","volume":"81","author":"R.T. Lee","year":"1988","unstructured":"Lee RT, Bloch KD, Pfeffer JM, et al.: Atrial natriuretic factor gene expression in ventricles of rats with spontaneous biventricular hypertrophy. J Clin Invest 1988, 81:431\u2013434.","journal-title":"J Clin Invest"},{"key":"74_CR45","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1172\/JCI118162","volume":"96","author":"O. Nakagawa","year":"1995","unstructured":"Nakagawa O, Ogawa Y, Itoh H, et al.: Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an \u201cemergency\u201d cardiac hormone against ventricular overload. J Clin Invest 1995, 96:1280\u20131287.","journal-title":"J Clin Invest"},{"key":"74_CR46","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1073\/pnas.94.15.8121","volume":"94","author":"D.D. D\u2019Angelo","year":"1997","unstructured":"D\u2019Angelo DD, Sakata Y, Lorenz JN, et al.: Transgenic Galpha q overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A 1997, 94:8121\u20138126.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"74_CR47","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1161\/01.CIR.97.19.1952","volume":"97","author":"K. Harada","year":"1998","unstructured":"Harada K, Komuro I, Shiojima I, et al.: Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation 1998, 97:1952\u20131959.","journal-title":"Circulation"},{"key":"74_CR48","doi-asserted-by":"crossref","first-page":"44012","DOI":"10.1074\/jbc.M106132200","volume":"276","author":"J.P. Kats van","year":"2001","unstructured":"van Kats JP, Methot D, Paradis P, et al.: Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice. Direct and indirect effects of angiotensin II on the heart. J Biol Chem 2001, 276:44012\u201344017.","journal-title":"J Biol Chem"},{"key":"74_CR49","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2215\/CJN.02231205","volume":"1","author":"K.A. Griffin","year":"2006","unstructured":"Griffin KA, Bidani AK: Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade. Clin J Am Soc Nephrol 2006, 1:1054\u20131065.","journal-title":"Clin J Am Soc Nephrol"},{"key":"74_CR50","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1161\/hy1101.099502","volume":"38","author":"P. Svensson","year":"2001","unstructured":"Svensson P, de Faire U, Sleight P, et al.: Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE substudy. Hypertension 2001, 38:E28\u2013E32.","journal-title":"Hypertension"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-008-0074-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-008-0074-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-008-0074-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T21:22:45Z","timestamp":1738876965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-008-0074-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["74"],"URL":"https:\/\/doi.org\/10.1007\/s11886-008-0074-5","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}